SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-054007
Filing Date
2024-06-20
Accepted
2024-06-20 07:30:08
Documents
5
Period of Report
2024-08-01

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea0207614-def14a_oramed.htm DEF 14A 323263
2 GRAPHIC image_001.jpg GRAPHIC 31114
3 GRAPHIC image_002.jpg GRAPHIC 28848
4 GRAPHIC image_003.jpg GRAPHIC 743935
5 GRAPHIC image_004.jpg GRAPHIC 594268
  Complete submission text file 0001213900-24-054007.txt   2250602
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35813 | Film No.: 241054068
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)